Cases & Deals

OncoHoldings negotiates exclusive license for family of cancer compounds from TGen

Clients OncoHoldings, Inc.

Jones Day represented OncoHoldings, Inc. in connection with an exclusive license of a family of small molecule selective inhibitors of Histone Deacetylases (HDAC) by the non-profit Translational Genomics Research Institute (TGen).

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.